PARP INHIBITOR BIOMARKERS MARKET ANALYSIS

Parp Inhibitor Biomarkers MarketSize and Trends

The global PARP inhibitor biomarkers market is estimated to be valued at US$ 907.1 million in 2023 and is expected to exhibit a CAGR of 24.9% during the forecast period (2023-2030).

Figure 1. Global PARP Inhibitor Biomarkers Market Share (%),By Product Type, 2023

Increasing prevalence of Cancer disease, rising geratic population and increasing awareness about Cancer and new Biomarkers releases and strategic efforts by prominent market competitors are favorably impacting the industry's growth. the high prevalence of Cancer, favorable health reimbursement, and increased awareness regarding Cancer among people and clinicians is a major factor in the PARP inhibitor biomarkers market, thereby contributing to the market growth.

Figure 2. Global PARP Inhibitor Biomarkers Market Value (US$ Million), by Region, 2023

Global PARP Inhibitor Biomarkers Market – Driver

Increasing prevalence of Cancer

Increasing prevalence of Cancer is expected to propel growth of the global PARP inhibitor biomarkers market over the forecast period. For instance, according to the article published by the World Health Organization, in February 2022, the age-standardized point prevalence and annual incidence rates of Cancer were 246.6 and 14.9 in 2019, which increased by 7.4% and 8.2% from 1990, respectively. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

Market Trends